Molecular mechanisms of ocular angiogenesis and development of therpeutic agents
Molecular mechanisms of ocular angiogenesis and development of therpeutic agents
批准号:
09557136
负责人:
YAMASHITA Hidetoshi
金额:
$7.68万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In diabetic retinopathy, vascular barrier breakdown, obstruction and new vessel formation are caused by any cytokines and growth factors, including vascular endothelial growth factor(VEGF), transforming growth factor-beta(TGF-beta)superfamily and interleukin-6(IL-6). The purpose of this presentation is to clarify the roles and the interaction among factors in the pathogenesis of proliferative diabetic retinopathy(PDR).The Expressions of VEGF, PIGF, TGF-beta superfamily(TGF-beta, activin A), interleukin-6(IL-6)in the intraocular humor and the pathological fibrovascular tissues obtained from PDR eyes were investigated. The correlation between the expression of cytokines/growth factors and clinical characteristics was inquired to know the roles in the pathogenesis of diabetic retinopathy. The concentrations of VEGF, PIGE and IL-6 increased in the intraocular humor from diabetic retinopathy eyes. In the pathological preretinal proliferative tissues obtained from PDR eyes, VEGF, TGF-b2, and … More activin A were expressed. The concentration of VEGF, blood-ocular barrier function and pathological changes of iris vessels were correlated. VEGF is speculated to play important roles in the breakdown of vascular barrier functions and new vessel formation in diabetic retinopathy. Concentrations of PIGF and VEGF in PDR eyes were correlated, because both are induced by hypoxia. Activin A counteracted the growth stimulation by VEGF in the cultured endothelial cells.The angiogenesis process is regulated by many growth factors and cytokines including VEGF and TGF-beta. In the next step, to investigate the molecular mechanisms of regulation of angiogenesis, angiogenic activity in vivo and the effects on cultured endothelial cells in vitro of VEGF and TGF-beta superfamily.Angiogenesis in vivo (CAM assay) : VEGF and TGF-beta induced angiogenesis. Activin A did not induce the angiogenesis.Effects on endothelial cells in vitro : VEGF stimulated 4 steps of angiogenesis. However, TGF-beta and activin A inhibited the endothelial cell function in vitro. These results suggest that the angiogenis activity in vivo and that in vitro may be differetnt, so both experimental systems are mandatory to evaluate the angiogenic activity of various cytokines. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Usui T.et al.: "Molecular mechanism of extracellular matrix production by transforming growth factor-β in corneal endothelial cells." Invest.Ophthalmol.Vis.Sci. 39. 1981-1989 (1998)
Usui T. 等人:“通过转化角膜内皮细胞中的生长因子-β 产生细胞外基质的分子机制。” Invest.Ophthalmol.Vis.Sci 39. 1981-1989 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ideta R.et al: "Roles of cytokines in diabetic retinopathy." Arch Ophthalmol. (印刷中).
Ideta R. 等人:“细胞因子在糖尿病视网膜病变中的作用”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamashita H.: "Functions of the transforming growth factor-beta superfamily in eyes." J Jpn Ophthalmol Soc. 101. 927-947 (1997)
Yamashita H.:“转化生长因子-β超家族在眼睛中的功能。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Usui T.et al.: "Molecular mechanism of extracellular matrix production by transforming growth factor-β in corneal endothelial cells." Invest Ophthalwol Vis Sci. 39. 1981-1989 (1998)
Usui T. 等人:“通过在角膜内皮细胞中转化生长因子-β 来产生细胞外基质的分子机制。”Invest Oіthwol Vis Sci. 39. 1981-1989 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ideta R,Yamashita H,et al: "Roles of cytokines in diabetic retinopathy" Arch Ophthalmol. (in press).
Ideta R、Yamashita H 等人:“细胞因子在糖尿病视网膜病变中的作用”Arch Ophasemol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 26 条
Comprehensive Social Scientific Study on Radioactive Waste Disposal Issues
-
批准号:19H04335
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.4万
-
财政年份:2019
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Molecular epidemiological study on choroidopathy in diabetic eyes
-
批准号:18K09439
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2018
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Molecular mechanisms of progression of diabetic retinopathy focusing inflammatory mechanisms by dendritic cells in vitreous
-
批准号:15K10832
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2015
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Research on policies for the promotion of locally initiated renewable energy projects
-
批准号:25281068
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.4万
-
财政年份:2013
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Molecular pathogenesis and strategic approach of treatment for diabetic retinopathy
-
批准号:24592617
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2012
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
New strategy to treat diabetic retinopathy using stabilization of hyalocyte-vasucular endothelial cell correlation
-
批准号:21592215
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
An analysis of the effects of the waste tax on the reduction of the final disposal of industrial wastes
-
批准号:20710036
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.75万
-
财政年份:2008
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Changes of retinal vascular structure in diabetic retinopathy andstrategy of treatment
-
批准号:19592004
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Molecular Mechanisms of Damage to Retinal Neuronal Cells in Diabetic Retinopathy and New Therapeutic Modalities
-
批准号:17591819
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Determination of treatment modalities for diabetic retinopathy and diabetic maculopathy -Strategic approach using molecular and cellular biological methods-
-
批准号:15591841
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Mutation analysis of tumors in ophthalmological area to to choose the treatment modalities---mutation analysis using paraffin specimens---
-
批准号:13671819
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2001
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Development of therapeutic agents and gene therapy by inhibiting new vessel formation
-
批准号:11671724
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:1999
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
MOLECULAR MECHANISMS OF CORNEAL WOUND HEALING AFTER PHOTO-REFRACTIVE CORNEAL SURGERY
-
批准号:11557127
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.64万
-
财政年份:1999
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Molecular biology of retinal development and retinal degeneration
-
批准号:09671787
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1997
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
Development of New Immunotherapy in Ophthalmology
-
批准号:60440079
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$21.18万
-
财政年份:1985
-
负责人:YAMASHITA Hidetoshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于VEGF/VEGFR信号通路探讨自拟创疡膏对慢性创面的作用机制研究
-
批准号:2026JJ80680
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:姜平
-
依托单位:
Decorin调控ADAMTS12 m6A甲基化与IL12B/VEGF免疫互作介导肥胖合并妊娠期糖尿病子代心血管疾病的作用研究
-
批准号:2026JJ81694
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗慧
-
依托单位:
协同靶向VE-PTP/VEGF重建胶质母细胞瘤血管稳态的双靶点抑制剂开发与机制研究
-
批准号:JCZRLH202601503
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
金黄跌打散联合海桐皮汤通过HIF-1α/VEGF通路干预新生血管形成防治软骨损伤的机制研究
-
批准号:2026JJ81074
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:钟炜钰
-
依托单位:
基于蛋白质组学探究VEGF转染的人脐带间充质干细胞改善小鼠急性肝衰竭的机制及验证研究
-
批准号:2026JJ81849
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈海鸥
-
依托单位:
化痰通络汤调控PIEZO1/ACSL4/VEGF轴阻断线粒体机械转导增强内皮细胞铁死亡抗性促缺血性中风后血管新生的机制研究
-
批准号:2026JJ81884
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱新华
-
依托单位:
IGF2BP2通过m6A甲基化修饰调控VEGF-C转录促进头颈鳞癌淋巴管生成的机制研究
-
批准号:JCZRQNB202600634
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
研究川崎病患者血清中VEGF水平与冠状动脉异常的相关性
-
批准号:2026JJ82691
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:鲁涛
-
依托单位:
养精通络方调控HIF-1α/VEGF信号通路调控“氧化应激-线粒体自噬”促进薄型子宫内膜修复的机制研究
-
批准号:2026JJ82186
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曾晶
-
依托单位: